PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'SIOOT, High School in Oxygen Ozone Therapy, University of Pavia, Italy; SIOOT INTERNATIONAL, Communian Clinic, Gorle Bergamo, Italy.\', \'Department of Drug Science, University of Pavia, Italy.\', \'Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Electronic address: salvatore.chirumbolo@univr.it.\', \'Venlo University B.V., Venlo, Netherlands.\', \'Department of Surgery, Dentistry, Paediatrics and Gynaecology Unit of Maxillo-Facial Surgery, University of Verona, Verona, Italy.\', \'SIOOT INTERNATIONAL, Communian Clinic, Gorle Bergamo, Italy; Department of Drug Science, University of Pavia, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(20)31494-610.1016/j.intimp.2020.106879
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32795898
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32795898>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32795898>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all